A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder

Psychological Medicine

Volumn 41, Issue 10, 2011, Pages 2159-2166

  Panahi, Y ^a   Moghaddam, B Rezazadeh ^b   Sahebkar, A ^a,c,d   Nazari, M Abbasi ^b   Beiraghdar, F ^a   Karami, G ^a   Saadat, A R ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Combat related PTSD; post traumatic stress disorder; randomized controlled trial; sertraline

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INTENTION TO TREAT ANALYSIS; IRAN; MALE; MIDDLE AGED; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; STANDARD; TREATMENT OUTCOME; VETERAN; WAR;

ADULT; DOUBLE-BLIND METHOD; HUMANS; INTENTION TO TREAT ANALYSIS; IRAN; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; VETERANS; WAR;

EID: 80054884853     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711000201     Document Type: Article

References (23)

1. Boscarino JA, Chang J (1999). Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research. Annals of Behavioral Medicine 21, 227-234.
2. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. Journal of the American Medical Association 283, 1837-1844. (Pubitemid 30207620)
3. Chung MY, Min KH, Jun YJ, Kim SS, Kim WC, Jun EM (2004). Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Human Psychopharmacology 19, 489-494. (Pubitemid 39378271)
4. Creamer M, Burgess P, McFarlane AC (2001). Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-Being. Psychological Medicine 31, 1237-1247. (Pubitemid 32975889)
5. Davidson JR, Hughes D, Blazer DG, George LK (1991). Post-traumatic stress disorder in the community: an epidemiological study. Psychological Medicine 21, 713-721.
6. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry 58, 485-492. (Pubitemid 32411330)
7. De Boer M, Op den Velde W, Falger PJ, Hovens JE, De Groen JH, Van Duijn H (1992). Fluvoxamine treatment for chronic PTSD: a pilot study. Psychotherapy and Psychosomatics 57, 158-163.
8. Dow B, Kline N (1997). Antidepressant treatment of posttraumatic stress disorder and major depression in veterans. Annals of Clinical Psychiatry 9, 1-5. (Pubitemid 27425013)
9. Friedman MJ (1997). Drug treatment for PTSD: answers and questions. Annals of the New York Academy of Sciences 821, 359-371.
10. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM (2007). Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. Journal of Clinical Psychiatry 68, 711-720. (Pubitemid 46841854)
11. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR (2000). Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Annals of Clinical Psychiatry 12, 101-105. (Pubitemid 30470156)
12. Kessler RC (2000). Posttraumatic stress disorder: the burden to the individual and to society. Journal of Clinical Psychiatry 61, 4-12; discussion 13-14.
13. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 52, 1048-1060.
14. Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu R, Smiga S, Tecott L, Neylan T (1996). Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. Journal of Clinical Psychiatry 57, 66-70; discussion 71-72.
15. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. American Journal of Psychiatry 158, 1982-1988. (Pubitemid 33104102)
16. Martenyi F, Brown EB, Zhang H, Koke SC, Prakash A (2002a). Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. British Journal of Psychiatry 181, 315-320. (Pubitemid 35178563)
17. Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC (2002b). Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry 63, 199-206. (Pubitemid 34407078)
18. Martenyi F, Soldatenkova V (2006). Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: analysis of the veteran group of a placebo-controlled, randomized clinical trial. European Neuropsychopharmacology 16, 340-349. (Pubitemid 43898670)
19. Resnick HS, Kilpatrick DG, Dansky BS, Saunders BE, Best CL (1993). Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. Journal of Consulting and Clinical Psychology 61, 984-991. (Pubitemid 24006588)
20. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD (2001). Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. Journal of Clinical Psychiatry 62, 860-868. (Pubitemid 33131172)
21. Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, Pynoos JD, Zatzick DF, Benedek DM, McIntyre JS, Charles SC, Altshuler K, Cook I, Cross CD, Mellman L, Moench LA, Norquist G, Twemlow SW, Woods S, Yager J; Work Group on ASD and PTSD; Steering Committee on Practice Guidelines (2004). Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. American Journal of Psychiatry 161, 3-31.
22. Zatzick DF, Marmar CR, Weiss DS, Browner WS, Metzler TJ, Golding JM, Stewart A, Schlenger WE, Wells KB (1997). Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans. American Journal of Psychiatry 154, 1690-1695. (Pubitemid 27516585)
23. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C (2002). Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. Journal of Clinical Psychopharmacology 22, 190-195. (Pubitemid 34289394)